Cited by 209Cancer, Lipids, and MetabolismLipid metabolism and biosynthesisSphingolipid Metabolism and Signaling

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Inhibition of Fatty Acid Synthase Attenuates CD44-Associated Signaling and Reduces Metastasis in Colorectal Cancer

Open access

Zaytseva, Yekaterina Y., Rychahou, Piotr G., Gulhati, Pat, Elliott, Victoria A., Mustain, William C., O'Connor, Kathleen, Morris, Andrew J., Sunkara, Manjula, Weiss, Heidi L., Lee, Eun Y., Evers, B. Mark·2012·Cancer Research

DOI 10.1158/0008-5472.can-11-4057PMC PMC3596828

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Fatty acid synthase (FASN) and ATP-citrate lyase, key enzymes of de novo lipogenesis, are significantly upregulated and activated in many cancers and portend poor prognosis. Even though the role of lipogenesis in providing proliferative and survival advantages to cancer cells has been described, the impact of aberrant activation of lipogenic enzymes on cancer progression remains unknown. In this study, we found that elevated expression of FASN is associated with advanced stages of colorectal cancer (CRC) and liver metastasis, suggesting that it may play a role in progression of CRC to metastatic disease. Targeted inhibition of lipogenic enzymes abolished expression of CD44, a transmembrane protein associated with metastases in several cancers including CRC. In addition, inhibition of lipogenic enzymes and reduced expression of CD44 attenuated the activation of MET, Akt, FAK, and paxillin, which are known to regulate adhesion, migration, and invasion. These changes were consistent with an observed decrease in migration and adhesion of CRC cells in functional assays and with reorganization of actin cytoskeleton upon FASN inhibition. Despite the modest effect of FASN inhibition on tumor growth in xenografts, attenuation of lipogenesis completely abolished establishment of hepatic metastasis and formation of secondary metastasis. Together, our findings suggest that targeting de novo lipogenesis may be a potential treatment strategy for advanced CRC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-4057

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global cancer statistics
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann‐Apitius, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,652
MET signalling: principles and functions in development, organ regeneration and cancer
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3012 · Cited by 1,272
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Zöller, M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3023 · Cited by 1,152
Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology
Kuhajda, F. P. (2000) · Nutrition · doi:10.1016/s0899-9007(99)00266-x · Cited by 801
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
Mashima, T., Seimiya, H., & TSURUO, T. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605007 · Cited by 569
mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways
Gulhati, P., Bowen, K. A., Liu, J., Stevens, P. D., Rychahou, P. G., Chen, M., Lee, E. Y., Weiss, H. L., O’Connor, K. L., Gao, T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4058 · Cited by 544
Self-citation
CD44 is required for two consecutive steps in HGF/c-Met signalingPreprint
Orian‐Rousseau, V., Chen, L., Sleeman, J. P., Herrlich, P. A., & Ponta, H. (2002) · Genes & Development · doi:10.1101/gad.242602 · Cited by 518

Show all 52 references

Sorted by citations

The metabolism of cancer cells during metastasis
Bergers, G., & Fendt, S. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-020-00320-2 · Cited by 974
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V., & Fendt, S. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.013 · Cited by 793
Inhibition of de novo palmitate synthesis by fatty acid synthase induces apoptosis in tumor cells by remodeling cell membranes, inhibiting signaling pathways, and reprogramming gene expression
Ventura, R., Mordec, K., Waszczuk, J., Wang, Z., Lai, J., Fridlib, M., Buckley, D., Kemble, G., & Heuer, T. S. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.06.020 · Cited by 301
Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
Fernández, L. P., de Cedrón, M. G., & de Molina, A. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.577420 · Cited by 234
Cancer metabolism in space and time: Beyond the Warburg effect
Danhier, P., Bański, P., Payen, V. L., Grasso, D., Ippolito, L., Sonveaux, P., & Porporato, P. E. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.001 · Cited by 230
Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis
Flaveny, C. A., Griffett, K., Elgendy, B., Kazantzis, M., Sengupta, M., Amelio, A. L., Chatterjee, A., Walker, J. K., Solt, L. A., Kamenecka, T. M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.05.007 · Cited by 209
Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer
Świerczyński, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2279 · Cited by 203
Lipid desaturation – the next step in targeting lipogenesis in cancer?
Peck, B., & Schulze, A. (2016) · FEBS Journal · doi:10.1111/febs.13681 · Cited by 185
miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
Xin, M., Qiao, Z., Li, J., Liu, J., Song, S., Zhao, X., Miao, P., Tang, T., Wang, L., Liu, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10020 · Cited by 179
Perinatal Exposure of Mice to the Pesticide DDT Impairs Energy Expenditure and Metabolism in Adult Female Offspring
Merrill, M. A. L., Karey, E., Moshier, E. L., Lindtner, C., Frano, M. R. L., Newman, J. W. I., & Buettner, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103337 · Cited by 178
ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer
Ye, Q., Cai, W., Zheng, Y., Evers, B. M., & She, Q. (2013) · Oncogene · doi:10.1038/onc.2013.122 · Cited by 168
Self-citation
Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration
Zaytseva, Y. Y., Harris, J. W., Mitov, M. I., Kim, J. T., Butterfield, D. A., Lee, E. Y., Weiss, H. L., Gao, T., & Evers, B. M. (2015) · Oncotarget · doi:10.18632/oncotarget.3783 · Cited by 153
Self-citation
Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth
Gao, Y., Islam, M. S., Tian, J., Lui, V. W. Y., & Xiao, D. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.015 · Cited by 144
The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells
Prochownik, E. V., & Wang, H. (2021) · Cells · doi:10.3390/cells10040762 · Cited by 150
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
Schcolnik‐Cabrera, A., Chávez-Blanco, A. D., Domínguez-Gómez, G., Taja‐Chayeb, L., Morales‐Bárcenas, R., Trejo‐Becerril, C., Pérez‐Cárdenas, E., González‐Fierro, A., & Dueñas‐González, A. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1471132 · Cited by 143
Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells
Li, P., Tian, W., & Ma, X. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-138 · Cited by 138
FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression
Heuer, T. S., Ventura, R., Mordec, K., Lai, J., Fridlib, M., Buckley, D., & Kemble, G. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2016.12.012 · Cited by 136
The Fatty Acid Synthase Inhibitor Orlistat Reduces the Growth and Metastasis of Orthotopic Tongue Oral Squamous Cell Carcinomas
Agostini, M., Almeida, L. Y., Bastos, D. C., Ortega, R. M., Moreira, F. S., Seguin, F., Zecchin, K. G., Raposo, H. F., Oliveira, H. C. F., Amoêdo, N. D., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1136 · Cited by 131
Lipids as mediators of cancer progression and metastasis
Vogel, F. C. E., Chaves‐Filho, A. B., & Schulze, A. (2024) · Nature Cancer · doi:10.1038/s43018-023-00702-z · Cited by 141
Lipogenesis in cancer progression (Review)
Mounier, C., Bouraoui, L., & Rassart, É. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2441 · Cited by 129
Colorectal Cancer and Metabolism
Brown, R. E., Short, S. P., & Williams, C. S. (2018) · Current Colorectal Cancer Reports · doi:10.1007/s11888-018-0420-y · Cited by 129
Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
Butler, E. B., Zhao, Y., Muñoz‐Pinedo, C., Lu, J., & Tan, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3009 · Cited by 126
Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer
Zaytseva, Y. Y., Rychahou, P. G., Le, A.-T., Scott, T. L., Flight, R. M., Kim, J. T., Harris, J., Liu, J., Wang, C., Morris, A. J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25361 · Cited by 123
Self-citation
CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
Wang, Z., Zhao, K., Hackert, T., & Zöller, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00097 · Cited by 127
Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors
Angeles, T. S., & Hudkins, R. L. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1245286 · Cited by 114
Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells
Drury, J., Rychahou, P. G., He, D., Jafari, N., Wang, C., Lee, E. Y., Weiss, H. L., Evers, B. M., & Zaytseva, Y. Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01185 · Cited by 111
Self-citation
Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism
Porporato, P. E., Payen, V. L., Baselet, B., & Sonveaux, P. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2100-2 · Cited by 115
Fatty Acid Synthase Mediates the Epithelial-Mesenchymal Transition of Breast Cancer Cells
Li, J., Dong, L., Wei, D., Wang, X., Zhang, S., & Li, H. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.7357 · Cited by 109
Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer
Avuthu, N., & Guda, C. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00013-22 · Cited by 114
Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways
Brandi, J., Dando, I., Pozza, E. D., Biondani, G., Jenkins, R. E., Elliott, V., Park, K., Fanelli, G., Zolla, L., Costello, E., et al. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.10.002 · Cited by 106
Self-citation
Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b
Wahdan-Alaswad, R. S., Cochrane, D. R., Spoelstra, N. S., Howe, E. N., Edgerton, S. M., Anderson, S. M., Thor, A. D., & Richer, J. K. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0188-8 · Cited by 104
Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer
Zaytseva, Y. Y., Elliott, V. A., Rychahou, P., Mustain, W. C., Kim, J. T., Valentino, J., Gao, T., O’Connor, K. L., Neltner, J. M., Lee, E. Y., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu042 · Cited by 104
Self-citation
The role of FAK in tumor metabolism and therapy
Zhang, J., & Hochwald, S. N. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.003 · Cited by 104
Up-Regulated FASN Expression Promotes Transcoelomic Metastasis of Ovarian Cancer Cell through Epithelial-Mesenchymal Transition
Jiang, L., Wang, H., Li, J., Fang, X., Pan, H., Yuan, X., & Zhang, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150711539 · Cited by 94
Cucurbitacin B and cancer intervention: Chemistry, biology and mechanisms (Review)
Garg, S., Kaul, S. C., & Wadhwa, R. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4203 · Cited by 95
Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer
Bian, Y., Yu, Y., Wang, S., & Li, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.108 · Cited by 91
The vital role of ATP citrate lyase in chronic diseases
Khwairakpam, A. D., Banik, K., Girisa, S., Shabnam, B., Shakibaei, M., Fan, L., Arfuso, F., Monisha, J., Wang, H., Mao, X., et al. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01863-0 · Cited by 87
The Heterogeneity of Lipid Metabolism in Cancer
Park, J. K., Coffey, N. J., Limoges, A., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_3 · Cited by 80
Fatty acid synthase promotes breast cancer metastasis by mediating changes in fatty acid metabolism
Xu, S., Chen, T., Dong, L., Li, T., Xue, H., Gao, B., Ding, X., Wang, H., & Li, H. (2020) · Oncology Letters · doi:10.3892/ol.2020.12288 · Cited by 78
CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3
Martincuks, A., Li, P.-C., Zhao, Q., Zhang, C., Li, Y., Yu, H., & Rodrı́guez-Rodrı́guez, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589601 · Cited by 79
The role of miR-320 in glucose and lipid metabolism disorder-associated diseases
Du, H., Zhao, Y., Yin, Z., Wang, D. W., & Chen, C. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.53419 · Cited by 68
Metabolic reprogramming in colorectal cancer: regulatory networks and therapy
Zhang, J., Zou, S., & Fang, L. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00977-w · Cited by 73
Lipid metabolism in colon cancer: Role of Liver X Receptor (LXR) and Stearoyl-CoA Desaturase 1 (SCD1)
Piccinin, E., Cariello, M., & Moschetta, A. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100933 · Cited by 71
De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer
Jafari, N., Drury, J., Morris, A. J., Onono, F. O., Stevens, P. D., Gao, T., Liu, J., Wang, C., Lee, E. Y., Weiss, H. L., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0199 · Cited by 69
Self-citation
Metformin treatment reduces temozolomide resistance of glioblastoma cells
Yang, S. H., Li, S., Lu, G., Xue, H., Kim, D., Zhu, J., & Liu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12859 · Cited by 66
Anoikis in cancer: The role of lipid signaling
Raeisi, M., Zehtabi, M., Velaei, K., Fayyazpour, P., Aghaei, N., & Mehdizadeh, A. (2022) · Cell Biology International · doi:10.1002/cbin.11896 · Cited by 62
Functional and clinical characteristics of focal adhesion kinases in cancer progression
Zhang, Z., Li, J., Jiao, S., Han, G., Zhu, J., & Liu, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1040311 · Cited by 66
PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer
Yamamoto, T., Hayashida, T., Masugi, Y., Oshikawa, K., Hayakawa, N., Itoh, M., Nishime, C., Suzuki, M., Nagayama, A., Kawai, Y., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2266 · Cited by 60
Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway
Chang, L., Fang, S., Chen, Y., Yang, Z., Yuan, Y., Zhang, J., Ye, L., & Gu, W. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1058-8 · Cited by 64
Fragment-Based Identification of an Inducible Binding Site on Cell Surface Receptor CD44 for the Design of Protein–Carbohydrate Interaction Inhibitors
Liu, L.-K., & Finzel, B. C. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000276 · Cited by 56
High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy
Lee, J. E., Lim, J. H., Hong, Y. K., & Yang, S. H. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2017.466 · Cited by 57
Antitumor effects of curcumin: A lipid perspective
Naeini, M. B., Momtazi‐Borojeni, A. A., Jaafari, M. R., Johnston, T. P., Barreto, G. E., Banach, M., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28262 · Cited by 57
Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma
Ghanbari, R., Mosakhani, N., Asadi, J., Nouraee, N., Mowla, S. J., Yazdani, Y., Mohamadkhani, A., Poustchi, H., Knuutila, S., & Malekzadeh, R. (2015) · Iranian Journal of Cancer Prevention · doi:10.17795/ijcp2329 · Cited by 54
Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression
Ye, L., Li, Y., Zhang, S., Wang, J., & Lei, B. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.05.002 · Cited by 55
SIRT1-Mediated Expression of CD24 and Epigenetic Suppression of Novel Tumor Suppressor miR-1185-1 Increases Colorectal Cancer Stemness
Wang, T., Chern, E., Hsu, C., Tseng, K.-C., & Chao, H. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3188 · Cited by 53
Lipid metabolism as a targetable metabolic vulnerability in colorectal cancer
Zaytseva, Y. (2021) · Cancers · doi:10.3390/cancers13020301 · Cited by 53
Self-citation
Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer
Negi, L. M. S., Jaggi, M., Joshi, V., Kar, R., & Talegaonkar, S. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.11.026 · Cited by 52
Inhibitors of Fatty Acid Synthesis and Oxidation as Potential Anticancer Agents in Colorectal Cancer Treatment
Mozolewska, P., Duzowska, K., Pakiet, A., Mika, A., & Śledziński, T. (2020) · Anticancer Research · doi:10.21873/anticanres.14487 · Cited by 52
The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer
Hon, K. W., Abidin, S. A. Z., Othman, I., & Naidu, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768861 · Cited by 53
There and back again: The journey of the estrogen-related receptors in the cancer realm
Tam, I. S., & Giguère, V. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.06.009 · Cited by 53
Increased HAGLR expression promotes non–small cell lung cancer proliferation and invasion via enhanced de novo lipogenesis
Lu, C., Ma, J., & Cai, D. (2017) · Tumor Biology · doi:10.1177/1010428317697574 · Cited by 50
Interplay between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem Cells
Daniel, Y., Lelou, E., Aninat, C., Corlu, A., & Cabillic, F. (2021) · Cancers · doi:10.3390/cancers13081973 · Cited by 52
Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer
Duan, J., Sun, L., Huang, H., WU, Z., WANG, L., & Liao, W. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4902 · Cited by 49
Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer
González-Guerrico, A. M., Espinoza, I. C., Schroeder, B., Park, C. H., Chandra Mohan, K. V. P., Khurana, A., Corominas-Faja, B., Cuyàs, E., Alarcón, T., Kleer, C. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9463 · Cited by 48
MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase
Cheng, C., Chen, Z.-Q., & Shi, X. (2014) · Tumor Biology · doi:10.1007/s13277-013-1546-9 · Cited by 46
Retracted
Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer
Abdelrahman, A. E., Rashed, H. E., Elkady, E., Elsebai, E. A., El-Azony, A., & Matar, I. (2019) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2019.01.002 · Cited by 43
Targeting fatty acid synthase with ASC‐J9 suppresses proliferation and invasion of prostate cancer cells
Wen, S., Niu, Y., Lee, S. O., Yeh, S., Shang, Z., Gao, H., Li, Y., Chou, F.-J., & Chang, C. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22468 · Cited by 42
Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway
Shen, C., Song, Y.-H., Xie, Y., Wang, X., Wang, Y., Wang, C., Liu, S., Xue, S.-L., Li, Y., Liu, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19348 · Cited by 43
Anti‐Metastatic and Anti‐Angiogenic Activities of Core–Shell SiO2@LDH Loaded with Etoposide in Non‐Small Cell Lung Cancer
Zhu, Y., Zhu, R., Wang, M., Wu, B., He, X., Qian, Y., & Wang, S. (2016) · Advanced Science · doi:10.1002/advs.201600229 · Cited by 41
Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients
Roseweir, A. K., Qayyum, T., Lim, Z. H., Hammond, R., Macdonald, A. I., Fraser, S., Oades, G. M., Aitchison, M., Jones, R. J., & Edwards, J. (2016) · BMC Cancer · doi:10.1186/s12885-016-2254-9 · Cited by 40
Complex Alterations of Fatty Acid Metabolism and Phospholipidome Uncovered in Isolated Colon Cancer Epithelial Cells
Hofmanová, J., Slavík, J., Cigánek, M., Ovesná, P., Tylichová, Z., Karasová, M., Zapletal, O., Straková, N., Procházková, J., Bouchal, J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136650 · Cited by 39
Elevated expression of fatty acid synthase and nuclear localization of carnitine palmitoyltransferase 1C are common among human gliomas
Wakamiya, T., Suzuki, S. O., Hamasaki, H., Honda, H., Mizoguchi, M., Yoshimoto, K., & Iwaki, T. (2014) · Neuropathology · doi:10.1111/neup.12132 · Cited by 39
Roles of fatty acid metabolism in tumourigenesis: Beyond providing nutrition (Review)
Yu, X., Ren, X., Liang, X., & Tang, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9577 · Cited by 38
Anticancer properties of the fatty acid synthase inhibitor TVB-3166 on oral squamous cell carcinoma cell lines
Aquino, I. G., Bastos, D. C., Zelaya, F. J. M. C., Teixeira, I. F., Salo, T. A., Coletta, R. D., & Graner, E. (2020) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2020.104707 · Cited by 38
Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota
Pan, S., Guo, Y., Hong, F., Xu, P., & Zhai, Y. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166281 · Cited by 37
In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation
Czumaj, A., Zabielska, J., Pakiet, A., Mika, A., Rostkowska, O. M., Makarewicz, W., Kobiela, J., Śledziński, T., & Stelmańska, E. (2019) · Anticancer Research · doi:10.21873/anticanres.13531 · Cited by 38
The Heterogeneity of Lipid Metabolism in Cancer
Park, J. K., Coffey, N. J., Limoges, A., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_3 · Cited by 38
Overexpression of fatty acid synthase attenuates bleomycin induced lung fibrosis by restoring mitochondrial dysfunction in mice
Shin, H., Park, S., Hong, J., Baek, A.-R., Lee, J.-H., Kim, D.-J., Jang, A., Chin, S. S., Jeong, S. H., & Park, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-36009-3 · Cited by 36
Inhibition of fatty acid synthase suppresses neovascularization via regulating the expression of VEGF-A in glioma
Zhou, Y., Jin, G., Mi, R., Zhang, J., Zhang, J., Xu, H., Cheng, S., Zhang, Y., Song, W., & Liu, F. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2249-6 · Cited by 36
Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigation
Negi, L. M. S., Talegaonkar, S., Jaggi, M., Verma, A. K., Verma, R., Dobhal, S., & Kumar, V. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.09.062 · Cited by 36
Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K/Akt signaling pathway in vitro
Liu, Z., MAO, J. H., Peng, A. F., Yin, Q., Zhou, Y., LONG, X. H., & HUANG, S. H. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1220 · Cited by 35
Application of luteolin nanomicelles anti-glioma effect with improvementin vitroandin vivo
Zheng, S., Cheng, Y., Teng, Y., Liu, X., Yu, T., Wang, Y., Liu, J., Hu, Y., Wu, C., Wang, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18019 · Cited by 35
Activation of c-Met and Upregulation of CD44 Expression Are Associated with the Metastatic Phenotype in the Colorectal Cancer Liver Metastasis Model
Elliott, V. A., Rychahou, P. G., Zaytseva, Y. Y., & Evers, B. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097432 · Cited by 35
Self-citation
Cancer cell metabolism regulates extracellular matrix degradation by invadopodia
van Horssen, R., Buccione, R., Willemse, M. P., Köker, Ş. C., Wieringa, B., & Attanasio, F. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.11.003 · Cited by 34
Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4)
Deshmukh, A. P., Arfuso, F., Newsholme, P., & Dharmarajan, A. (2018) · Cancers · doi:10.3390/cancers10020040 · Cited by 35
Hyaluronic acid decorated lipid nanocarrier for MDR modulation and CD-44 targeting in colon adenocarcinoma
Negi, L. M. S., Jaggi, M., Joshi, V., Kar, R., & Talegaonkar, S. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.09.005 · Cited by 33
Brain Metastases from Colorectal Cancer: Microenvironment and Molecular Mechanisms
Zang, Y.-W., Gu, X., Xiang, J., & Chen, Z. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131215784 · Cited by 36
Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer
Peng, Y., Xu, C., Wen, J., Zhang, Y., Wang, M., Liu, X., Zhao, K., Wang, Z., Liu, Y., & Zhang, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.704038 · Cited by 30
Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an in-vitro, in-vivo and mechanistic investigation
Negi, L. M. S., Talegaonkar, S., Jaggi, M., & Verma, A. K. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1497039 · Cited by 31
Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss
Bastos, D. C., Ribeiro, C. F., Ahearn, T. U., Nascimento, J., Pakula, H., Clohessy, J. G., Mucci, L. A., Roberts, T. M., Zanata, S. M., Zadra, G., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5587 · Cited by 31
The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways
Guerram, M., Jiang, Z., Yousef, B. A., Hamdi, A. M., Hassan, H. M., Yuan, Z., Luo, H.-W., Zhu, X., & Zhang, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4156 · Cited by 31
Malic Enzyme 1 (ME1) is pro-oncogenic in ApcMin/+ mice
Fernandes, L. M., Al‐Dwairi, A., Simmen, R. C. M., Marji, M., Brown, D. M., Jewell, S. W., & Simmen, F. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-32532-w · Cited by 30
SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis
Xu, T., Li, X., Zhao, W., Wang, X., Jin, L., Feng, Z., Li, H., Zhang, M., Tian, Y., Hu, G., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03053-4 · Cited by 32
Epigallocatechin gallate triggers apoptosis by suppressing de novo lipogenesis in colorectal carcinoma cells
Khiewkamrop, P., Surangkul, D., Srikummool, M., Richert, L., Pekthong, D., Parhira, S., Somran, J., & Srisawang, P. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13391 · Cited by 29
NMU signaling promotes endometrial cancer cell progression by modulating adhesion signaling
Lin, T., Wu, F.-J., Chang, C.-L., Li, Z., & Luo, C. (2016) · Oncotarget · doi:10.18632/oncotarget.7169 · Cited by 29
The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signaling
Hu, S., Heng, H., Yang, F., Wang, M., Liu, G., Xiang, Y., & Miao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1735873 · Cited by 32
Metabolic implication of tumor:stroma crosstalk in breast cancer
Morandi, A., & Chiarugi, P. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1124-7 · Cited by 29
An Inhibitor of Fatty Acid Synthase Thioesterase Domain with Improved Cytotoxicity against Breast Cancer Cells and Stability in Plasma
Lupien, L. E., Dunkley, E. M., Maloy, M. J., Lehner, I. B., Foisey, M. G., Ouellette, M. E., Lewis, L. D., Pooler, D. B., Kinlaw, W. B., & Baures, P. W. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258947 · Cited by 27
Phytocompounds Targeting Metabolic Reprogramming in Cancer: An Assessment of Role, Mechanisms, Pathways, and Therapeutic Relevance
Khan, A., Siddiqui, S. I., Husain, S. A., Mazurek, S., & Iqbal, M. A. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c01173 · Cited by 29
Small interfering RNA‑mediated knockdown of fatty acid synthase attenuates the proliferation and metastasis of human gastric cancer cells via the mTOR/Gli1 signaling pathway
Sun, L., Yao, Y., Pan, G., Zhan, S., Shi, W., Lü, T., Yuan, J., Tian, K., Jiang, L., Song, S., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8648 · Cited by 26

Authors: Zaytseva, Y. Y., Rychahou, P. G., Gulhati, P., Elliott, V. A., Mustain, W. C., O'Connor, K., Morris, A. J., Sunkara, M., Weiss, H. L., Lee, E. Y., & Evers, B. M.
Affiliations: University of Kentucky (US)
Authors' Affiliations: 1Markey Cancer Center, Departments of 2Surgery and 3Pathology and Laboratory Medicine, 4Division of Cardiovascular Medicine, and 5Gill Heart Institute, University of Kentucky, Lexington, Kentucky
Corresponding author: Evers, B. Mark
ORCID: Zaytseva, Yekaterina Y.
Rychahou, Piotr G.
Gulhati, Pat
Mustain, William C.
Morris, Andrew J.
Sunkara, Manjula
Weiss, Heidi L.
Lee, Eun Y.
Evers, B. Mark
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2012-03-14
Volume: 72
Issue: 6
Pages: 1504-1517
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-11-4057
PMC: PMC3596828
OpenAlex: W1997243908
Cited by: 208
References: 52
Citations by year: 2026: 6 · 2025: 17 · 2024: 19 · 2023: 12 · 2022: 17 · 2021: 19 · 2020: 17 · 2019: 11 · 2018: 18 · 2017: 8 · 2016: 19 · 2015: 13 · 2014: 22 · 2013: 7 · 2012: 3
FWCI: 4.88
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
UKnowledge (University of Kentucky) (submittedVersion)
Funders: National Cancer Institute (P20CA150343, R01CA109136, P20CA1530343, T32CA165990)
National Institute of General Medical Sciences (GM-50388, R01GM050388)
National Center for Research Resources (S10RR026884, S10RR024598, P20RR021954)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Keywords: fatty acid synthase, ATP citrate lyase, de novo lipogenesis, colorectal cancer, liver metastasis, CD44, C-MET signaling, Akt signaling, focal adhesion kinase, paxillin, cell migration, cell adhesion, actin cytoskeleton
MeSH terms: Animals, Humans, Liver Neoplasms, Male, Mice, Nude, Colorectal Neoplasms, Signal Transduction, Down-Regulation, Hyaluronan Receptors, Proto-Oncogene Proteins c-met, Xenograft Model Antitumor Assays, Cell Line, Tumor, Lipogenesis, Oncogene Protein v-akt, Mice, Focal Adhesion Kinase 1, Paxillin, Gene Knockdown Techniques, Fatty Acid Synthases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of Fatty Acid Synthase Attenuates CD44-Associated Signaling and Reduces Metastasis in Colorectal Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks